ATARA BIOTHERAPEUTICS, INC. Impairment of Long-Lived Assets Held-for-use
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-03-16
- ATARA BIOTHERAPEUTICS, INC. impairment of long-lived assets held-for-use for the quarter ending 2014-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 | ||
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 | ||
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | ||
| 2022-12-31 | $0.00 10-K · filed 2023-02-08 | ||
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | ||
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | ||
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | ||
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | ||
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | ||
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | ||
| 2015-12-31 | $0.00 10-K · filed 2016-03-04 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $0.00 10-K · filed 2015-02-26 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |